Fetuin-A and YKL-40 levels are strongly associated with the presence and short-term severity of metabolic syndrome, while hsCRP reflects longitudinal changes in metabolic burden.
Do inflammatory biomarkers (Fetuin-A, YKL-40, hsCRP) correlate with the diagnosis and severity of Metabolic Syndrome?
Patients evaluated for Metabolic Syndrome (MetS)
Measurement of inflammatory biomarkers (Fetuin-A, YKL-40, hsCRP)
Presence and severity of Metabolic Syndromesurrogate
Fetuin-A, YKL-40, and hsCRP may serve as useful biomarkers for tracking the severity and longitudinal metabolic burden of Metabolic Syndrome.
Fetuin-A and YKL-40 levels are strongly associated with both the presence and short-term changes in MetS severity. hsCRP appears to reflect longitudinal changes in metabolic burden. These findings suggest that selected inflammatory biomarkers may provide additional insight into the inflammatory and metabolic dynamics of MetS.
Building similarity graph...
Analyzing shared references across papers
Loading...
Hilal Bektaş Uysal
Hüseyin Bayğın
Elif Duygu Topan
Metabolic Syndrome and Related Disorders
Adnan Menderes University
Sivas State Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Uysal et al. (Fri,) reported a other. Fetuin-A and YKL-40 levels are strongly associated with the presence and short-term severity of metabolic syndrome, while hsCRP reflects longitudinal changes in metabolic burden.
www.synapsesocial.com/papers/69e47440010ef96374d8ffda — DOI: https://doi.org/10.1177/15578518261443921